AMZN is a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock shows a bullish trend, strong Q1 financial growth, and broad Wall Street support with rising price targets. While the latest price action is slightly weak and the stock is not cheap on momentum alone, the overall evidence favors buying now rather than waiting.
AMZN is in an uptrend: SMA_5 is above SMA_20, and SMA_20 is above SMA_200, which is bullish for trend-following investors. MACD histogram is positive at 0.505, though it is contracting, so momentum is still positive but not accelerating. RSI_6 at 69.42 is near the upper end of neutral and suggests the stock is not deeply overbought. Price at 270.82 is just above pivot 267.338 and below R1 275.894, implying the stock is trading near a breakout area. Short-term downside probabilities from similar candlestick patterns are mildly negative, but the broader trend remains constructive.

Amazon Web Services remains a major long-term catalyst, with analysts citing AI-driven acceleration, stronger backlog visibility, and improving custom silicon positioning. Q1 earnings were strong, with revenue up 16.61% YoY, net income up 76.65% YoY, and EPS up 74.84% YoY. Gross margin also improved to 51.82%. Amazon Pharmacy's same-day Ozempic delivery is another incremental growth and ecosystem expansion catalyst.
AWS reported a service disruption tied to overheating at a data center in Northern Virginia, which is a near-term operational negative. News also noted slower-than-expected temperature restoration progress, which could affect services and inventory flow. The stock closed slightly lower on the day, and the recent pattern-based outlook points to some short-term weakness. Trading signals show no special buy signal today.
In Q1 2026, Amazon delivered strong growth: revenue rose to 181.519B, up 16.61% YoY; net income increased to 30.255B, up 76.65% YoY; EPS grew to 2.78, up 74.84% YoY; and gross margin improved to 51.82, up 2.51% YoY. This is a strong quarter and supports a long-term bullish view.
Recent analyst action has been clearly positive: multiple firms raised price targets after Q1, including Fubon to Buy with a $320 target, Baird to $300, Raymond James to $280, Morgan Stanley to $330, Scotiabank to $325, RBC to $320, Roth Capital to $300, Telsey to $315, Needham to $300, and Evercore ISI to $315. The overall Wall Street view is bullish, with repeated Outperform/Overweight/Buy ratings and higher targets reflecting confidence in AWS, AI, and margin expansion. On the downside, the only real concern is that AWS growth was slightly below the highest bar some investors expected, but pros still see the long-term story intact and improving.